{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-041168","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2023-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.592593+00:00","generated_at":"2026-06-19T09:24:25.781023+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Galera raises $30M in registered direct offering of stock and warrants","bullets":["Offering of 14,320,000 shares at $2.095/share plus warrants to buy 14,320,000 shares at $1.97.","Gross proceeds of $30M; net to fund avasopasem pre-commercialization, rucosopasem development, and working capital.","Closing expected February 17, 2023; 90-day lock-up for officers and directors.","Piper Sandler acted as sole placement agent; 6% placement fee on gross proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-041168","json":"https://secwatch.observer/filing/0001193125-23-041168.json","markdown":"https://secwatch.observer/filing/0001193125-23-041168.md","text":"https://secwatch.observer/filing/0001193125-23-041168.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/0001193125-23-041168-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/d424770d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T09:24:25.781023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}